Cytogenetic Biochemical
|
|
- Matilda York
- 5 years ago
- Views:
Transcription
1 Diagnostic Laboratories Test Menu Molecular Cytogenetic Biochemical
2 Table of Contents Lab Directors & Genetic Counselors...2 Molecular Diagnostic Lab Next Generation Sequencing Panels...3 Biochemical Diagnostic Lab Enzyme Panels...7 Individual Enzymes...8 Analytes...8 Monitoring Tests...8 Cytogenetic Laboratory Microarrays...9 Chromosome Analysis...9 FISH for Congenital Abberations...9 Oncology Mutation Analysis...9 Hematological Studies...10 FISH Hemotology Panels...10 Individual Probes...10
3 Lab Directors Mike Friez, PhD, FACMG Director of Diagnostic Labs Molecular Biochemical Cytogenetic Jennifer A. Lee, PhD, FACMG Lead Molecular Director Tim Wood, PhD, FACMG Director Barbara DuPont, PhD, FACMG Senior Director Fatima Abidi, PhD Technical Director Laura Pollard, PhD, FACMG Associate Director Alka Chaubey, PhD, FACMG Director Julie R Jones, PhD, FACMG Director of Clinical Genomics Sequencing Program Taraka Donti, PhD Assistant Director Genetic Counselors Robin Fletcher, MS, CGC Laboratory Genetic Counselor Kellie Walden, MS, CGC Laboratory Genetic Counselor -2-
4 Molecular Diagnostic Testing Next Generation Sequencing Aortic Dysfunction or Dilation and Related Disorders Panel genes - Arterial Hypertension Panel 11 genes - Bardet-Biedl Syndrome Panel 26 genes - Brugada Syndrome Panel 18 genes Comprehensive Cardiac Panel 108 genes + Comprehensive Pulmonary Panel 93 genes - Cone-Rod Dystrophy Panel 37 genes - Congenital Stationary Night Blindness Panel 14 genes Connective Tissue Disroders Panel Cornelia de Lange Panel Craniosynostosis Panel Dilated Cardiomyopathy (DCM)/Arrhythmogenic Cardiomyopathy Panel Epilepsy/Seizure Panel Hearing Loss Panel 35 genes 5 genes 8 genes 51 genes 145 genes 91 genes - Hermansky-Pudlak Syndrome and Pulmonary Fibrosis Panel 25 genes Hypertrophic Cardiomyopathy Panel 20 genes - Leber Congenital Amaurosis Panel 24 genes - Long QT Panel 16 genes Lysosomal Storage Disease Panel 75 genes - Macular Degeneration 24 genes Neuronal Ceroid Lipofuscinoses Panel Non-immune Hydrops Panel 9 genes 87 genes - Ocular Albinism and Hermansky Pudlak Panel 17 genes - Optic Atrophy and Early Glaucoma Panel 34 genes Overgrowth/Macrocephaly Panel 16 genes - Peroxisome Biogenesis Disorders Panel 12 genes + Primary Ciliary Dyskinesia and Cystic Fibrosis Panel 42 genes RASopathy Panel 23 genes - Retinitis Pigmentosa Panel 91 genes Rett/Angelman Syndrome 2nd Tier Sequencing Panel Rhabdomyolysis and Metabolic Myopathies Panel Skeletal Dysplasia Panel 21 genes 47 genes 10 genes - Surfactant dysfunction and respiratory distress in premature infants Panel 8 genes Syndromic Autism Panel Vascular Disorders Panel 83 genes 21 genes + X-Linked Intellectual Disability (XLID) Panel 114 genes Whole exome sequencing analysis is available for trios and singletons. Custom panel and single gene requests are accepted. Contact the lab for more details.
5 Syndrome Gene Sequencing Del/Dup Present in panel 3-Methylcrotonyl-CoA Carboxylase Deficiency MCCC1, MCCC2 Aarskog syndrome FGD1 + Adrenoleukodystrophy, X-linked ABCD1 + Allan-Herndon-Dudley syndrome SLC16A2/MCT8 Alpha-Mannosidosis MAN2B1 Aminoglycoside-induced Hearing Loss MTRNR1 Angelman syndrome: Methylation analysis, UBE3A Sequencing and Deletion/Duplication, UPD15 analysis ARX-related spectrum ARX + Aspartylglucosaminuria AGA Atypical Rett syndrome CDKL5 + ATRX syndrome ATRX + Batten Disease, Neuronal Ceroid Lipofuscinosis 3 CLN3 Beckwith Wiedemann syndrome Methylation Beta-Mannosidosis MANBA Biotinidase deficiency BTD Borjeson-Forssman-Lehmann syndrome PHF6 + Cardio-Facio-Cutaneous (CFC) syndrome Tier 1 BRAF Tier 2 MAP2K1, MAP2K2 Tier 3 KRAS Carnitine Palmitoyltransferase Deficiency 1A CPT1A Carnitine Palmitoyltransferase II Deficiency CPT2 CASK-related Intellectual Disability CASK + CHARGE syndrome CHD7 Christianson syndrome (Angelman-like syndrome) SLC9A6 + Citrullinemia Type I ASS1 Coffin-Lowry syndrome RPS6KA3 + Congenital Disorder of Glycosylation, Ia PMM2 Congenital Disorder of Glycosylation, Ib MPI Congenital Disorder of Glycosylation, Ic ALG6 Congenital Rett Variant FOXG1 Connexin 26 GJB2 Cornelia de Lange Syndrome NIPBL, SMC1A, RAD21, SMC3, or HDAC8 + Costello syndrome Tier 1 (First Coding Exon) HRAS Tier 2 (Remaining Exons) HRAS Cystic Fybrosis CTFR + Creatine Transporter Deficiency SLC6A8 + DCX-related spectrum DCX + Duchenne/Becker Muscular Dystrophy DMD + Early Infantile Epileptic Encephalopathy 4 STXBP1 Ectrodactyly, Ectodermal Dysplasia, Clefting syndrome TP63/p63 Fabry Disease GLA FG syndrome MED12 + FGFR2-related disorders FGFR2-4-
6 Molecular Diagnostic Testing Cont.. Syndrome Gene Sequencing Del/Dup Present in panel FGFR3 -related disorders (selected exons) FGFR3 FLNA related disorders FLNA + Fragile X syndrome FMR1 Triplet Repeat Analysis + FRAXE syndrome AFF2 Triplet Repeat Analysis + Fucosidosis FUCA1 Galactosemia, classic GALT Galactosialidosis CTSA Gaucher Disease GBA Glutaric Acidemia, Type I GCDH Greig cephalopolysyndactyly syndrome GLI3 Glycogen Synthase Deficiency GYS2 GM1 Gangliosidosis GLB1 Hemochromatosis - Targeted Mutation Analysis HFE Hay-Wells syndrome TP63/p63 Hunter syndrome, MPS II IDS + Hurler, Hurler-Scheie, and Scheie syndrome, MPS I IDUA Isolated Split-Hand/Foot TP63/p63 Kabuki syndrome MLL2 Krabbe Disease GALC Leopard Syndrome Tier 1 PTPN11 Tier 2 RAF Sequencing of exons 7, 14 & 17 Tier 3 BRAF Lujan-Fryns syndrome MED12 Marfan syndrome FBN1 Maroteaux-Lamy syndrome, MPS VI ARSB MCAD ACADM Metachromatic Leukodystrophy ARSA Morquio syndrome, type A, MPS IVA GALNS Morquio syndrome, type B, MPS IVB GLB1 Mucolipidosis II/IIIA GNPTAB/GNPTG Myotonic Dystrophy DM1 Triplet Repeat Analysis Myotubular Myopathy, X-linked MTM1 + Neuronal Ceroid Lipofuscinosis type 1 PPT1 Neuronal Ceroid Lipofuscinosis type 2 TPP1 Niemann-Pick Disease A/B (Acid sphingomyelinase) SMPD1-5-
7 Syndrome Gene Sequencing Del/Dup Present in panel Noonan syndrome Tier 1 PTPN11 Tier 2 SOS1 Tier 3 RAF1, KRAS Sequencing & SHOC2 p.s2g Tier4 BRAF, MAP2K1, NRAS OPHN1-related X-linked Intellectual Disability OPHN1 + Ornithine transcarbamylase deficiency OTC + Pelizaeus-Merzbacher Disease, Spastic paraplegia 2 PLP1 + Phenylketonuria PAH Pitt-Hopkins syndrome TCF4 POLG1 related disorders POLG1 Pompe Disease GAA Prader-Willi syndrome UPD 15 & methylation PTEN related Disorders PTEN Renpenning syndrome PQBP1 + Rett syndrome MECP2 + Russell Silver syndrome UPD 7 & 11p15.5 related methylation Sandhoff Disease HEXB Saethre-Chotzen syndrome TWIST1 Sanfilippo syndrome Type A, MPS IIIA SGSH Sanfilippo syndrome Type B, MPS IIIB NAGLU Sanfilippo syndrome Type C, MPS IIIC HGSNAT Sanfilippo syndrome Type D, MPS IIID GNS Short-Chain Acyl-CoA Dehydrogenase (SCAD) ACADS Sialidosis NEU1 Simpson-Golabi-Behmel syndrome type 1 GPC3 + Sly syndrome, MPS VII GUSB Sotos syndrome NSD1 Tay-Sachs Disease HEXA Succinyl CoA:3-oxoacid CoA transferase (SCOT) OXCT1 Thrombosis Panel: Factor V Leiden & Prothrombin Targeted Mutation Analysis Uniparental disomy Chromosomes 7, 14, 15 VLCAD Deficiency ACADVL X-inactivation analysis X-linked, Female Limited Epilepsy with ID PCDH19 + X-linked Hydrocephalus L1CAM + X-linked Opitz G/BBB syndrome MID
8 Biochemical Diagnostic Testing Enzyme Panels Dried Blood Spot Lysosomal Enzyme Panel Alpha-mannosidosis, Aspartylglucosaminuri, Beta-mannosidosis, Fabry Disease, Fucosidosis, Gaucher disease, GM1 Gangliosidosis/ Morquio type B (MPS IVB), Hunter syndrome (MPS II), Hurler syndrome (MPS I), Krabbe Disease, Niemann-Pick A/B, Pompe disease, Sanfilippo syndrome type B (MPS IIIB), Schindler/Kanzaki Disease, Tay Sachs/Sandhoff Disease Hydrops Panel Galactosialidosis, Gaucher Disease, GM 1 gangliosidosis, Sialidosis, Sly syndrome, MPS VII Lysosomal Storage Disease Panel Alpha-Mannosidosis, Aspartylglucosaminuria, Beta-Mannosidosis,Fabry Disease, Fucosidosis, Gaucher Disease, GM 1 gangliosidosis/ Morquio type B (MPS IVB), Hurler syndrome; MPS I, Krabbe Disease, Metachromatic Leukodystrophy, Niemann-Pick A/B, Schindler/ Kanzaki Disease, Tay Sachs/Sandhoff Disease Morquio syndrome Panel, MPS IV Morquio type A & Morquio type B Mucopolysaccharidosis (MPS) Enzyme Panel Hurler syndrome (MPS I), Hunter syndrome (MPS II), Sanfilippo syndrome; Type A (MPS IIIA), Type B (MPS IIIB), Type C (MPS IIIIC), & Type D (MPS IIID), Morquio syndrome; Type A (MPS IVA), Type B (MPS IVB), Maroteaux-Lamy syndrome (MPS VI), Sly syndrome (MPS VII) Multiple Sulfatase Deficiency Panel Arylsulfatase B, Iduronate-2-sulfatase, and N-acetyl-galactosamine-6-sulfatase Neurological (Sphingolipidoses) Panel Fabry disease, Gaucher Disease, GM1 gangliosidosis, Krabbe Disease, Metachromatic Leukodystrophy, Neuronal Ceroid Lipofuscinosis 1, Neuronal Ceroid Lipofuscinosis 2( Simplify to 1 & 2?), Niemann-Pick A/B, Tay Sachs/Sandhoff Disease Sanfilippo syndrome Panel, MPS III Sanfilippo syndrome, Types A, B, C and D (MPS IIIA, IIIB, IIIC, and IIID) Oligosaccharidoses Panel Alpha-Mannosidosis, Aspartylglucosaminuria, Beta-Mannosidosis, Fucosidosis, GM1 gangliosidosis, Schindler/Kanzaki Disease, Sialidase only if fibroblasts are submitted -7-
9 Individual Enzymes Alpha-mannosidosis α-mannosidase Aspartylglucosaminuria Aspartylglucosaminidase Beta-mannosidosis β-mannosidase Biotinidase biotinidase deficiency Fabry disease α-galactosidase Fucosidosis α-fucosidase Gaucher Disease β-glucosidase GM1 Gangliosidosis β-galactosidase Hunter syndrome, MPS II iduronate-2-sulfatase Hurler syndrome, MPS I α-iduronidase Krabbe Disease galactocerebrosidase Maroteaux Lamy syndrome, MPS VI arylsulfatase B Metachromatic leukodystrophy arylsulfatase A Morquio, type A N-acetyl-galactosamine-6-sulfatase Morquio, type B β-galactosidase Mucolipidosis II / III Plasma screen Neuronal Ceroid Lipofuscinosis 1 Palmitoyl-protein thioesterase 1 Neuronal Ceroid Lipofuscinosis 2 Tripeptidyl peptidase 1 Niemann-Pick A/B Acid sphingomyelinase Pompe Disease (Glycogen Storage Disease Type II) α-1,4-glucosidase Sanfilippo A Heparan-N- sulfatase Sanfilippo B N-acetyl-α-glucosaminidase Sanfilippo C Acetyl CoA:glucosamine N-acetyltransferase Sanfilippo D N-acetyl glucosamine-6-sulfatase Schindler/Kanzaki Disease N-acetyl alpha galactosaminidase Sialidosis α-neuraminidase, sialidase Sly syndrome, MPS VII β-glucuronidase Tay Sachs/Sandhoff Disease β-hexosaminidase Biochemical Analytes Plasma Urine CSF Serum Acylcarnitine profile Amino acids Carnitine, total and free Creatine/GAA Creatine Kinase Galactose-1-phosphate (RBC) Glutarylcarnitine (C5-DC) Glycosaminoglycans, total quantitative Homocysteine Oligosaccharide Analysis via LC-MS/MS Organic acids Orotic acid Sialic acid Transferrin isoelectric focusing (CDG screening) Tryptophan MPS Analysis includes quantitative HS/DS/CS/KS & total GAGs Biochemical Genetics Profile: amino acids, acylcarnitine profile, carnitine, & organic acids Storage Disease Screening Panel: Includes: MPS analysis (quantitative HS/DS/CS/KS & GAGs) Oligosaccharide analysis, and Sialic Acid, total and free Urine Mucopolysaccharidosis Monitoring Total GAGs DS HS KS CS MPS I/II MPS III MPS IV MPS VI MPS VII -8-
10 Cytogenetic Diagnostic Testing Microarray -Whole Genome SNP Microarrays CytoScan Dx Assay (FDA Cleared array)* *Can only be ordered for certain indications: developmental delay intellectual disability congenital anomalies dysmorphic features CytoScan HD Array -Custom Exon Array (725 genes) Can be ordered as single gene, two genes, group of genes, or full array for all genes -Acute Lymphocytic Leukemia (ALL) Array -Acute Myelocytic Leukemia (AML) Array -Chronic Lymphocytic Leukemia (CLL) Array -Chronic Myelocytic Leukemia (CML) Array -OncoScan Microarray (any FFPE tumor Tissue) -Pregnancy Loss/POC Microarray -Prenatal Whole Genome SNP Microarray -Targeted Infertility Microarray -X-Chromosome CGH Microarray 105K Chromosome Analysis Routine blood High resolution Rule out mosaicism Solid tissue Amniotic fluid CVS Oncology Mutation Analysis AML (FLT3-ITD, & FLT3-TKD mutations; NPM1 Codon 12 Lung Adenocarcinoma EGFR amplificaiton and mutation analysis BRAF mutation (V600E) PTEN mutatin analysis Lung Adenocarcinoma panel (includes EGFR amplification mutation analysis, BRAF & PTEN mutation analysis Brain Tumor IDH1 R132H mutation 1p/19q co-deletion NEK1 deletion TP53 deletion CDKN2A/CDKN28 deletion EGFR Amplification PTEN deletion NF1 deletion Adult Brain Tumor Panel (includes 98 genes listed Melanoma BRAF mutation analysis (V600E & V600K) Melanoma Array (Includes genomic gains, losses, and loss of heterozygosity Fish for Congenital Abberations Disorder Androgen Receptor Angelman syndrome Autism Chromosome Xq12 Cri-du-chat syndrome 5p- 15q11q13 dup15q12 DiGeorge/VCF 22q11.2 Kallmann syndrome Miller-Dieker syndrome Xp p13 Phelan-McDermid syndrome 22q13.3 Prader-Willi syndrome 15q11q13 Smith Magenis syndrome 17p11.2 Sex Reversal/Ambiguous Genitalia Panel Steroid Sulfatase Deficiency (STS)/X-linked Icthyosis Trisomy screen includes SRY/Xcen & X/Y dual assay probes Xp , 18, 21, X, Y Williams syndrome 7q11.23 X/Y dual assay x,y Wolf-Hirschhorn syndrome 4p- -9-
11 Hematological and Oncological Disease Studies FISH Panels & Specific Probes Bone Marrow chromosome Stimulated/Unstimulated blood FISH Hematology Panels Acute Lymphocytic Leukemia Acute Myelocytic Leukemia Acute Promyelocytic Leukemia Chronic Lymphocytic Leukemia Chronic Myelocytic Leukemia Chronic Myelomonocytic Leukemia Multiple Myeloma Myelodysplastic States Non-Hodgkins Lymphoma Pediatric Acute Lymphoblastic Leukemia Reflex Panel for IgH breakapart Includes t(8;14), t(14;18), t(11;14) Individual Probes (Interphase and/or Metaphase) MYC (2p24.1) D7S486 (7q31) MLL (11q3) TOP2A (17q21) ALK (2p23) C-MYC (8q24) ETV6/TEL (12p13) SYT (18q11.2) BCL6 (3q27) p16 (9p21) Retinoblastoma (RB1) MALT1 (18q21) CSF1R (5q33-q34) 9q34 D13S319 (13q14) BCL2 (18q21) EGR-I (5q31) PTEN (10q23) IgH (14q32) D20S108 (20q12) MYB (6q23) Cyclin D1/CCND1 (11q13) CBFB (inv16) 20q13 EGFR (7p12) ATM (11q22.3) p53 (17p13.1) EWSR1 (22q12) -10-
12 @ ggc.org 106 Gregor Mendel Circle Greenwood, SC (800) Fax (864) Mission Statement The Greenwood Genetic Center is a nonprofit institute organized to provide clinical genetic services and laboratory testing, to develop educational programs and materials, and to conduct research in the field of medical genetics.
CPT Code and Price List
CPT Code and Price List 2018 CPT Codes Molecular Tests Next Generation Sequencing Panels (2) Sanger Sequencing (3-4) Deletion/Duplication (MLPA) (4) Methylation Analysis (4) Targeted Analysis (4) Trinucleotide
More informationDate of commencement: February Principal Investigator Dr. Jayesh J. Sheth CASE RECORD FORM
ICMR-FRIGE-MULTICENTRIC LSDs Project Foundation for Research in Genetics & Endocrinology [FRIGE], FRIGE House, Jodhpur Gam road, Satellite, Ahmedabad-380015 Tel no: 079-26921414, Fax no: 079-26921415 E-mail:
More informationFRAMBU. Resource Centre for Rare Disorders
FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory
More informationClinical Approach to Diagnosis of Lysosomal Storage Diseases
Clinical Approach to Diagnosis of Lysosomal Storage Diseases M. Rohrbach, MD, PhD FMH Pädiatrie und FMH Medizinische Genetik Abteilung Stoffwechsel Universitätskinderklinik Zürich Lysosomal storage disorders
More informationUtility of Microarrays in Molecular Genetics
Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,
More informationTEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days
TEST MENU CANCER/LEUKEMIA CHROMOSOME ANALYSIS Chromosome Analysis Bone Marrow 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis Bone Marrow Core 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome
More informationCHRONIC MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases
More informationWhat s New in Newborn Screening?
What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is mandated and administered by the Illinois Department of
More informationMetabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen
Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10
More informationThe role of the laboratory in diagnosing lysosomal disorders
The role of the laboratory in diagnosing lysosomal disorders Dr Guy Besley, formerly Willink Biochemical Genetics Unit, Manchester Children s Hospital, Manchester M27 4HA, UK. Lysosomal disorders What
More informationWhat s New in Newborn Screening?
What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is administered by the Illinois Department of Public Health.
More informationBROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.
More informationSeptember 04, 2008
27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates September 04, 2008 Dear Valued Client: As you may be aware, in recent years there has been a tremendous challenge in
More informationN.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017
Tests and Profiles Tests Method Sample Needed TAT Genetic Consultation / - All samples to be sent at 2 8 C. Counseling 1 Urine MRST - 15 ml Urine 24 hrs 2 Sr. Ammonia, Lactate, Sugar Fuji Dry Chem 2 ml
More informationAll diseases on Foresight
All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency
More informationPREDICAGEN LLC REPORT
The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because
More informationA Rare disease: MPS III San Filippo disease
A Rare disease: MPS III San Filippo disease Annick Raas-Rothschild, MD Pediatrician-Medical Geneticist Director of the Rare Diseases institute Institute of Genetics Sheba Tel Hashomer Medical Center Annick.rothschild@sheba.health.gov.il
More informationGet a more complete picture into your patient's pregnancy with PreSeek
PRENATAL Expecting a baby is an exciting and mysterious time. And it s natural for your patient to wonder if they have a healthy pregnancy. Introducing PreSeek, the most comprehensive, single gene, cell-free
More informationNeurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018
Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive
More informationC3, C4, C5, C6 2. & C7
Overview 1. Glucose conversion to pentoses & NADPH Precursors of nucleic acids, ATP, NAD, FAD, CoA 2. Inter-conversion of C3, C4, C5, C6 & C7 saccharides Glucose or fructose dietary input Glycogen 3. Nucleotide-linked
More informationPrevalence of lysosomal storage diseases in Portugal
(2004) 12, 87 92 & 2004 Nature Publishing Group All rights reserved 1018-4813/04 $25.00 www.nature.com/ejhg ARTICLE Rui Pinto 1,2, Carla Caseiro 1, Manuela Lemos 1, Lurdes Lopes 1, Augusta Fontes 1, Helena
More informationMucopolysaccharidoses diagnostic approaches
Mucopolysaccharidoses diagnostic approaches George Ruijter Center for Lysosomal and Metabolic Diseases Erasmus University Medical Center Rotterdam, The Netherlands 1/35 / 58 2 / 58 2/35 Mucopolysaccharidoses
More informationBest Practice Guidelines for the Biochemical Investigation of Patients with Foetal and Neonatal Hydrops
National Metabolic Biochemistry Network Best Practice Guidelines for the Biochemical Investigation of Patients with Foetal and Neonatal Hydrops INTRODUCTION Hydrops is defined as the presence of skin oedema
More informationNutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
More informationNeonatal Screening for Lysosomal Storage Disorders (LSD) by Tandem Mass Spectrometry (MSMS)
Neonatal Screening for Lysosomal Storage isorders (LS) by Tandem Mass Spectrometry (MSMS) Enzo Ranieri and Samantha Stark 1 Head, Neonatal Screening Centre & Biochemical Genetics (G&MP) irectorate of Genetics
More informationdevseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders
ACSL4 Mental/retardation,/XBlinked/63 XLBR ADSL Adenylosuccinase/Deficiency AR AFF2 Mental/retardation,/XBlinked,/FRAXE/type XLBR ALG6 Congenital/disorder/of/glycosylation/type/Ic AR ANK3 Mental/retardation,/autosomal/recessive/37
More informationStandard Therapies - Cord Blood
A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical
More informationCYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING
INTRODUCTION The Cytogenetics Laboratory offers a comprehensive array of chromosome investigations for cancers, constitutional abnormalities, and prenatal and postnatal diagnosis. Analyses are performed
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:
More informationLab Prior Authorization
Lab Prior Authorization On July 22, 2015, BlueCross BlueShield of South Carolina announced that it will partner with Avalon Healthcare Solutions (Avalon) to administer a comprehensive suite of laboratory
More informationClinical Cytogenomics Laboratory. Laboratory. Leading diagnostics for better medicine. Beaumont
Clinical Cytogenomics Laboratory Leading diagnostics for better medicine Beaumont Laboratory Beaumont Laboratory s Clinical Cytogenomics Lab Genome decoding is essential Knowledge of variations in genome
More informationPrices listed correspond to institutional rates only; please contact the lab for insurance rates.
Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test TAT ** Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative)
More informationAddressing the challenges of genomic characterization of hematologic malignancies using microarrays
Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Sarah South, PhD, FACMG Medical Director, ARUP Laboratories Department of Pediatrics and Pathology University
More informationMEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)
Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with
More informationERNDIM DPT Schemes. Common sample Sialidosis type I. Istanbul, 31 August Dr Christine Vianey-Saban, CHU Lyon
ERNDIM DPT Schemes Common sample 2010 Sialidosis type I Dr Christine Vianey-Saban, CHU Lyon christine.saban@chu-lyon.fr Patient information on form at referral 43 year old woman who presented progressive
More informationF or many years it has been recognised that a range of
1305 ORIGINAL ARTICLE Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2500 cases from a single centre G Anderson, V V Smith,
More informationYour single-source laboratory solution. FISH Probe Library
Your single-source laboratory solution. FISH Probe Library Alphabetical List by Probe with Clinical Indication Probe Clinical Indication 1p36 (TP73)/19q13 (GLTSCR) 1q21 (CKS1B) 5q (CSF1R/RPS14) 7q (MDFIC)
More informationGlycoproteins and Mucins. B.Sopko
Glycoproteins and Mucins B.Sopko Content Glycoproteins: Structures and Linkages Interconversions and activation of dietary sugars Other pathways of sugar nucleotide metabolism Biosynthesis of oligosaccharides
More informationGeneral Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name Middle
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University Hospitals NHS Foundation Trust, Level 1, The Women s Centre John Radcliffe Hospital University Hospitals NHS Foundation Trust OX3
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:
More informationDate of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.)
PATIENT INFORMATION Last Name First M.I. CLINICAL LABORATORY Date of Birth Gender Ethnicity/Family History Male Female Unknown Molecular Diagnotics Patient or Sample ID# Institutional Account # (415) 514-8488
More informationTECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays
TECHNICAL NOTICE The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays December 2012 The notation (MAAA) indicates "Multianalyte Assay with
More informationRole of Molecular Genetic Assessment for Autism in Clinical Setting
Role of Molecular Genetic Assessment for Autism in Clinical Setting Young Shin Kim, MD, MS, MPH, PhD Director STAR Center for ASD and NDDs Psychiatric Genetic Epidemiology Associate Professor Dept. of
More informationLeading Article. Enzyme Assays on Dried Blood Filter Paper Samples for Specific Detection of Selected Inherited Lysosomal Storage Diseases
103 Leading Article Enzyme Assays on Dried Blood Filter Paper Samples for Specific Detection of Selected Inherited Lysosomal Storage Diseases GABRIEL CIVALLERO 1, MAIRA BURIN 1,2, JUREMA DE MARI 1, MARLI
More informationThe Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem
The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non
More information1. Diagnosis of Lysosomal Storage Disorders in Australia. 2. Comparison of Incidence/prevalence of lysosomal storage diseases in different country
List of Tables: 1. Diagnosis of Lysosomal Storage Disorders in Australia 2. Comparison of Incidence/prevalence of lysosomal storage diseases in different country 3. Relative frequency of LSD in Portugal
More informationGeneral Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name MM/ DD
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
SW Thames Regional Genetics Laboratory, Jenner Wing, SGUL Cranmer Terrace London SW17 0RE Contact: Mr John Short Tel: +44 (0) 208 725 5332 Fax: +44 (0) 208 725 3440 E-Mail: swtrgl@stgeorges.nhs.uk Website:
More informationFABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease
Ophthalmologic Signs of Genetic Neurological Disease ES ROACH,MD. Ophthalmologic Signs of Genetic Neurological Disease Conjunctival lesions Corneal lesions Lesions of iris & lens Retinal vascular lesions
More informationCMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012.
January 1, 2012 Re: 2012 AMA CPT Code Changes Dear Valued Client: The American Medical Association (AMA) has made Current Procedural Terminology (CPT) code changes to the 2012 edition of the CPT coding
More information7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics
SESSION 7 Medical Genetics Hemoglobinopathies and Biochemical Genetics J a v a d F a s a J a m s h i d i U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 Hemoglobinopathies
More informationOut-Patient Billing CPT Codes
Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB
More informationGenetics and Genomics: Applications to Developmental Disability
Tuesday, 12:30 2:00, B1 Objective: Genetics and Genomics: Applications to Developmental Disability Helga Toriello 616-234-2712 toriello@msu.edu Identify advances in clinical assessment and management of
More informationAccount # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5
Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition
More informationCenters for Medicare and Medicaid Services
Centers for Medicare and Medicaid Services Clinical Laboratory Fee Schedule Annual Laboratory Public Meeting June 25, 2018 Anthony Sireci, MD, Msc Association for Molecular Pathology Outline Germline Procedures
More informationSAMPLE. Carrier Screening Results Report v2.2 Page 1/8
MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:
More informationpanel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders
NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel
More informationDNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History. Tuesday, April 16, 2013
DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History Tuesday, April 16, 2013 Objectives Recognize the importance & impact of newborn screening Describe the process of newborn screening
More informationPrices listed correspond to institutional rates only; please contact the lab for insurance rates.
Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,
More informationPrices listed correspond to institutional rates only; please contact the lab for insurance rates.
Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Genomic Diagnostics Laboratory (GDL) Manchester Centre for Genomic Medicine St Mary's Hospital Oxford Road Manchester M13 9WL Contact: Lorraine
More informationBIOCHEMICAL DIAGNOSIS OF DISEASES CAUSING OLIGOSACCHARIDURIA BY MASS SPECTROMETRY
BIOCHEMICAL DIAGNOSIS OF DISEASES CAUSING OLIGOSACCHARIDURIA BY MASS SPECTROMETRY Pedro Ruiz-Sala, Isaac Ferrer-López Centro de Diagnóstico de Enfermedades Moleculares CEDEM, Universidad Autónoma de Madrid,
More informationNewborn Screening and Studies of Lysosomal Storage Diseases in CFOH
Newborn Screening and Studies of Lysosomal Storage Diseases in CFOH Chinese Foundation of Health National Yang-Ming University Director: Dr. Chuan-Chi Chiang Speaker: Hsuan-Chieh Liao (Joyce) 1 Newborn
More informationThe Center for PERSONALIZED DIAGNOSTICS
The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)
More informationMolecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.
Molecular Oncology & Pathology Hereditary Cancer Somatic Cancer Liquid Biopsy Next-Gen Sequencing qpcr Sanger Sequencing Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine
More informationGeneral Approach to Genetic Testing
Protocol General Approach to Genetic Testing (20491) (Formerly Genetic Testing for Inherited Disorders) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization Yes Review Dates:
More informationNewborn Screening for Lysosomal Storage Diseases in Missouri. Outline
Newborn Screening for Lysosomal Storage Diseases in Missouri Dr. Kathy Grange Division of Genetics and Genomic Medicine Department of Pediatrics Washington University Outline Brief overview of clinical
More informationLysosomes are cytoplasmic organelles that contain. Current status of diagnosis and treatment of lysosomal storage diseases in China
Current status of diagnosis and treatment of lysosomal storage diseases in China Yu Huang and Nanbert Zhong Beijing, China and New York, USA Lysosomal storage diseases (LSDs) are a group of inherited disorders
More informationUpdate on the management of neurometabolic disorders in children.
Update on the management of neurometabolic disorders in children. Jane Ashworth Consultant Paediatric Ophthalmologist Manchester Royal Eye Hospital, UK Professor Kristina Fahnehjelm St Eriks Eye Hospital,
More informationMETABOLISM OF ACYLGLYCEROLS AND SPHINGOLIPDS. Ben S. Ashok MSc.,FAGE.,PhD., Dept. of Biochemistry
METABOLISM OF ACYLGLYCEROLS AND SPHINGOLIPDS Ben S. Ashok MSc.,FAGE.,PhD., Dept. of Biochemistry STORAGE AND MEMBRANE LIPIDS STORAGE LIPIDS Mainly as triacylglycerols (triglycerides) in adipose cells Constitute
More informationGenetic Testing for Inherited Conditions
Genetic Testing for Inherited Conditions Policy Number: 2018-101 Effective Date: January 26, 2018 Review Date: January 26, 2018 Next Review Date: January 26, 2019 Important Information - Please Read Before
More informationGenetics Evaluation, Referrals, and More What To Do Next
Genetics Evaluation, Referrals, and More What To Do Next Carol L Greene, MD, FAAP, FACMG John B Moeschler, MD, MS, FAAP, FACMG Thursday, June 28 12:00-12:30pm Central Time Out for Genetics Webinar Series
More informationDevelopments in Laboratory Genetics
Developments in Laboratory Genetics Rachel Butler rachel.butler@wales.nhs.uk The Impact of Genomics on Public Health Where are we now? Single gene disorders Core disorders Newborn screening (CF, MCAD)
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4
More informationMOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY
MOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY Intellectual disability (ID) or mental retardation is characterized by significant limitations in cognitive abilities and social/behavioral adaptive
More informationA. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia
OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Accredited to ISO 15189:2012 Laboratory Genetics Level 2B, Laboratory Medicine Queen Elizabeth University Hospital Govan Road Glasgow G51
More informationCorporate Medical Policy. Policy Effective October 9, 2018
Corporate Medical Policy Enzyme Replacement Therapy (ERT) for Lysosomal Storage File Name: Origination: Last CAP Review: Next CAP Review: Last Review: enzyme_replacement_therapy_for_lysosomal_storage_disorders
More informationThe University of Chicago Genetic Services Laboratories
Aceruloplasminemia testing CP sequencing Aceruloplasminemia CP deletion/duplication Albinism testing Albinism Sequencing Panel (20 genes Albinism Deletion/Duplication Panel (20 genes Alstrom syndrome testing
More informationEvolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University
Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome
More informationMultiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016
Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics
More informationLysosomal Enzymes in fibroblasts
ERNDIM Administration Office Manchester Centre for Genomic Medicine 6 th Floor, St Mary's Hospital, Oxford Road, Manchester M13 9WL, United Kingdom. Tel: +44 161 276 6741 Fax: +44 161 850 1145 Email: admin@erndim.org
More informationThe first non-invasive prenatal test that screens for single-gene disorders
The first non-invasive prenatal test that screens for single-gene disorders the evolution of NIPT A non-invasive prenatal test that screens multiple genes for mutations causing severe genetic disorders
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationMetabolism of acylglycerols and sphingolipids. Martina Srbová
Metabolism of acylglycerols and sphingolipids Martina Srbová Types of glycerolipids and sphingolipids 1. Triacylglycerols function as energy reserves adipose tissue (storage of triacylglycerol), lipoproteins
More information23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function
1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency
More informationDisclosures. Learning Objectives. Inheritance patterns. Lysosomal function. Mucopolysaccharidoses (MPS): Keys to Early Recognition and Intervention
39 th National Conference on Pediatric Health Care March 19-22, 2018 CHICAGO Disclosures Mucopolysaccharidoses (MPS): Keys to Early Recognition and Intervention Lindsay Torrice, MSN, CPNP PC Clinical Instructor
More informationComprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS
Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for
More informationLysosomal storage diseases (LSDs) are a group of genetic disorders that result from defective
NEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. PLEASURE, MD Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases David A. Wenger, PhD; Stephanie Coppola, BS; Shu-Ling Liu, MD Lysosomal
More informationHEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS
ACQUIRED ANEMIAS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are
More informationMLPA SAMPLES USER GUIDE
MLPA SAMPLES USER GUIDE MLPA microdeletion studies Requirements: 1-2 mls (minimum) of peripheral blood in a lithium heparin tube (green or orange top) AND 1-2 mls of peripheral blood in a EDTA tube (purple
More informationCLL Complete SM Report
Reported: 02/01/2012 Σ CGI ID No:5 Client:r Client Address: CLINICAL DATA: Lymphoma No CBC results provided. CLL Complete SM Report FINAL DIAGNOSIS: CD19+ B cell lymphoma, ZAP-70 + (44%), with borderline
More informationMOLECULAR SERVICES. mlabs.umich.edu
MOLECULAR SERVICES mlabs.umich.edu 800.862.7284 PICTURED ON LEFT IS MARWAN TAYEH, PH.D, CLINICAL ASSISTANT PROFESSOR, PEDIATRICS - GENETICS, ON RIGHT IS TODD ACKLEY, LABORATORY MANAGER MLabs is a full-service
More informationOncology Cytogenetics Diagnostic Service - User Guide 2014
Oncology Cytogenetics Diagnostic Service - User Guide 2014 Contact details Address: Cytogenetics Department 5 th Floor Tower Wing Guy s Hospital Great Maze Pond London SE1 9RT General enquiries 0207 188
More informationWhole exome sequencing Gene package Hereditary Congenital Defects version 3.1,
Whole Exome Sequencing Gene package Hereditary Congenital Defects, version 3.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired
More informationInborn Error Of Metabolism :
Inborn Error Of Metabolism : Inborn Error Of Metabolism inborn error of metabolism are a large group of hereditary biochemical diseases in which specific gene mutation cause abnormal or missing proteins
More informationACMG/CAP Cytogenetics CY
www.cap.org Cytogenetics Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services ACMG/CAP Cytogenetics CY Analyte CY Challenges per Shipment
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Building 9 Contact: Dr Catherine Sturgeon BioQuarter Tel: +44 (0)131-2426885 Little France Road Fax: +44 (0)131-242-6882 E-Mail: c.sturgeon@ed.ac.uk Websites: http://edqas.org EH16 4UX Proficiency Testing
More information